75
Views
17
CrossRef citations to date
0
Altmetric
Review

New anti-epileptic drugs

&
Pages 1497-1510 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Meir Bialer. (2006) New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opinion on Investigational Drugs 15:6, pages 637-647.
Read now
Jürgen Bauer & Markus Reuber. (2003) Medical treatment of epilepsy. Expert Opinion on Emerging Drugs 8:2, pages 457-467.
Read now
Michael Van Ameringen, Catherine Mancini, Peter Farvolden & Jonathan Oakman. (2000) Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI. Expert Opinion on Investigational Drugs 9:10, pages 2215-2231.
Read now

Articles from other publishers (13)

Amanda M. Drachnik, Harshita Kumari, Collin M. Mayhan, Drew A. Fowler, Wei G. Wycoff, Charles L. Barnes, John E. Adams, Carol A. Deakyne & Jerry L. Atwood. (2017) Conversion of Pregabalin to 4-Isobutylpyrrolidone-2. Journal of Pharmaceutical Sciences 106:10, pages 3095-3102.
Crossref
Celene M. Amabile & Arvind Vasudevan. (2013) Ezogabine: A Novel Antiepileptic for Adjunctive Treatment of Partial‐Onset Seizures. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:2, pages 187-194.
Crossref
Władysław Lasoń, Monika Dudra-Jastrzębska, Konrad Rejdak & Stanisław J. Czuczwar. (2011) Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacological Reports 63:2, pages 271-292.
Crossref
Luis F. Pacheco Otalora, Frank Skinner, Mauro S. Oliveira, Bianca Farrell, Massoud F. Arshadmansab, Tarun Pandari, Ileana Garcia, Leslie Robles, Gerardo Rosas, Carlos F. Mello, Boris S. Ermolinsky & Emilio R. Garrido-Sanabria. (2011) Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic rats. Brain Research 1368, pages 308-316.
Crossref
Philippa Delahoy, Sally Thompson & Ian C Marschner. (2010) Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. BMC Neurology 10:1.
Crossref
Jin-Tai Yu & Lan Tan. (2008) Diffusion-weighted magnetic resonance imaging demonstrates parenchymal pathophysiological changes in epilepsy. Brain Research Reviews 59:1, pages 34-41.
Crossref
Greg Warner & David P Figgitt. (2005) Pregabalin. CNS Drugs 19:3, pages 265-272.
Crossref
R.R Leker & M.Y Neufeld. (2003) Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Research Reviews 42:3, pages 187-203.
Crossref
Renato Galli, Enrica Bonanni, Chiara Pizzanelli, Michelangelo Maestri, Ludovico Lutzemberger, Filippo Sean Giorgi, Alfonso Iudice & Luigi Murri. (2003) Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation. Epilepsy & Behavior 4:2, pages 185-191.
Crossref
Geraldine M. Ferron, Jeffrey Paul, Richard Fruncillo, Lyette Richards, Norbert Knebel, John Getsy & Steven Troy. (2013) Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers. The Journal of Clinical Pharmacology 42:2, pages 175-182.
Crossref
Daniel F. Chollet. (2002) Determination of antiepileptic drugs in biological material. Journal of Chromatography B 767:2, pages 191-233.
Crossref
E. A. Lukyanetz, V. M. Shkryl & P. G. Kostyuk. (2002) Selective Blockade of N‐Type Calcium Channels by Levetiracetam. Epilepsia 43:1, pages 9-18.
Crossref
Andrew Nicolson & John Paul Leach. (2001) Future Prospects for the Drug Treatment of Epilepsy. CNS Drugs 15:12, pages 955-968.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.